.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Moodys
Chubb
Teva
Citi
UBS
Cantor Fitzgerald
Colorcon
Novartis

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018310

« Back to Dashboard
NDA 018310 describes LYMPHAZURIN, which is a drug marketed by Covidien and is included in one NDA. It is available from one supplier. Additional details are available on the LYMPHAZURIN profile page.

The generic ingredient in LYMPHAZURIN is isosulfan blue. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the isosulfan blue profile page.

Summary for 018310

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018310

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LYMPHAZURIN
isosulfan blue
INJECTABLE;INJECTION 018310 NDA UNITED STATES SURGICAL CORPORATION 63261-250 63261-250-21 5 mL in 1 VIAL, SINGLE-USE (63261-250-21)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Fish and Richardson
Baxter
Dow
Harvard Business School
Citi
Healthtrust
AstraZeneca
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot